Skip to content
Home » Tagipmet XR

Tagipmet XR

    Tagipmet XR

    Tagipmet XR (Sitagliptin + Metformin HCl Sustained Release) 50 mg / 1000 mg tablet belongs to a group of medicines known as dipeptidyl peptidase-4 (DPP-4) inhibitors and biguanides.

    It shows effectiveness by increasing the level of incretins to control blood sugar. It also helps by restoring your body’s proper response to insulin.

    Tagipmet XR

    Package Contains: It contains 14 tablets of 50 mg / 1000 mg.

    Composition:

    Each tablet contains:

     Sitagliptin (as phosphate) 50mg

     Metformin HCl (Sustained Release) 1000mg

    Product Specifications: HNL Specs.

    Uses: This combination medicine is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes.

    Dosage & Instructions: To be sold and used on the prescription of a registered medical practitioner only. For details see the enclosed leaflet.

    Keep out of reach of children. Store below 30°C in a dry place. Protect from light. Detailed prescribing information is available at www.highnoon-labs.com ^(https://medicineslist.com/goto/http://www.highnoon-labs.com)

    Precautions: It should not be used in patients with diabetic ketoacidosis. Use with caution in hepatic impairment and heart failure patients.

    Do not drive, use machinery, or do any activity after taking this medicine. Consult your doctor before breastfeeding. Please consult your doctor when taking this medicine if you are pregnant.

    Side effects: It can cause nausea, vomiting, stomach upset, diarrhea, headache, or a metallic taste in the mouth may occur. A tablet may also appear in your stool.

    Tagipmet XR back

    Links:

    Manufactured by: Highnoon Laboratories (Pvt.) Ltd. Welcome To Highnoon Laboratories Limited ^(https://medicineslist.com/goto/https://highnoon-labs.com/)

    You can buy it online at: Tagipmet Xr 50/1000mg Tablets ^(https://medicineslist.com/goto/https://dvago.pk/products/tagipmet_xr_501000mg_tablets)

     

    By: Zunaira Liaqat

    Leave a Reply

    Your email address will not be published. Required fields are marked *